Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravasc

Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravasc

First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp., a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today ann…

US FDA grants 510(k) clearance for hybrid coronary imaging system

Conavi Medical has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its next-generation hybrid coronary imaging system. The milestone positions the company to initiate its US commercial launch expected in the second half of 2026 and to expand its hybrid intravascular imaging technology. The Conavi system integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) technologies into a …